OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • The OncLive Insider app is live!
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Frontline Therapy In Follicular Lymphoma

home / insights / fl-frontline-therapy
Optimal Strategies to Help Diagnose Follicular Lymphoma

EP. 1: Optimal Strategies to Help Diagnose Follicular Lymphoma

July 9th 2019
Risk Assessment for Patients With Follicular Lymphoma

EP. 2: Risk Assessment for Patients With Follicular Lymphoma

July 9th 2019
Initiating Therapy in Follicular Lymphoma

EP. 3: Initiating Therapy in Follicular Lymphoma

July 9th 2019
Frontline Treatment Regimens in Follicular Lymphoma

EP. 4: Frontline Treatment Regimens in Follicular Lymphoma

July 9th 2019
The National LymphoCare Study in Follicular Lymphoma

EP. 5: The National LymphoCare Study in Follicular Lymphoma

July 9th 2019
The GALLIUM Study in Follicular Lymphoma

EP. 6: The GALLIUM Study in Follicular Lymphoma

July 9th 2019
FL: Interpreting and Applying GALLIUM Data in Practice

EP. 7: FL: Interpreting and Applying GALLIUM Data in Practice

July 9th 2019
Obinutuzumab Versus Rituximab in Frontline FL

EP. 8: Obinutuzumab Versus Rituximab in Frontline FL

July 9th 2019
Treating Relapsed/Refractory Follicular Lymphoma

EP. 9: Treating Relapsed/Refractory Follicular Lymphoma

July 9th 2019
Treating Follicular Lymphoma: Addressing Unmet Needs

EP. 10: Treating Follicular Lymphoma: Addressing Unmet Needs

July 9th 2019
Risk Stratification in Follicular Lymphoma

EP. 11: Risk Stratification in Follicular Lymphoma

July 9th 2019
Frontline Treatment for Follicular Lymphoma

EP. 12: Frontline Treatment for Follicular Lymphoma

July 9th 2019
Untreated Follicular Lymphoma and the Role of MRD Testing

EP. 13: Untreated Follicular Lymphoma and the Role of MRD Testing

July 9th 2019
Second-Line Treatment for Follicular Lymphoma

EP. 14: Second-Line Treatment for Follicular Lymphoma

July 9th 2019
The GADOLIN and GALEN Trials for Follicular Lymphoma

EP. 15: The GADOLIN and GALEN Trials for Follicular Lymphoma

July 9th 2019
The SWOG 1608 and Phase Ib/II Trials for Follicular Lymphoma

EP. 16: The SWOG 1608 and Phase Ib/II Trials for Follicular Lymphoma

July 9th 2019
Looking Ahead in the Treatment of Follicular Lymphoma

EP. 17: Looking Ahead in the Treatment of Follicular Lymphoma

July 9th 2019
Challenges in the Treatment of Follicular Lymphoma

EP. 18: Challenges in the Treatment of Follicular Lymphoma

July 9th 2019

Latest Conference Coverage

Final PICCOLO Data Underscore Mirvetuximab Soravtansine’s Efficacy in Later-Line Frα+ Platinum-Sensitive Ovarian Cancer

First-Line Rucaparib Maintenance Reduces Progression Risk Across Prognostic Subgroups in HRD– High-Grade Ovarian Cancer

Raludotatug Deruxtecan Shows Activity in Platinum-Sensitive Ovarian Cancer

Relacorilant/Nab-Paclitaxel Is Associated With Survival Improvement in Platinum-Resistant Ovarian Cancer After Short Platinum-Free Interval

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact